USPTO serial 86825955
PHYTO INNOVA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- LOOK, JEFFREY J
- Law office
- TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with PHYTO INNOVA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
North Vancouver, B.C., CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew R. Wilmot
Matthew R. Wilmot STOEL RIVES LLP760 SW NINTH AVENUE, SUITE 3000PORTLAND, OR 97205UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Botanical and botanically derived extracts for use in the manufacture of cosmetics; Diagnostic preparations and reagents for medical laboratory and research use; Body care and toiletry products, namely, body, hand and facial creams, bath and skin lotions, skin moisturizers and moisturizing lotions, shampoo, hair conditioners and body wash; Topical herbal creams, gels, salves, sprays, balms and ointments for analgesic purposes; Medicinal herb extracts; Medicinal herbal extracts for medical purposes; Medicinal herbal preparations; Medicinal herbs; Medicinal herbs in dried or preserved form; Pharmaceutical and nutraceutical preparations and pharmaceutical and nutraceutical substances containing plant extracts and plant-derived ingredients for the treatment of metabolic diseases and disorders, namely, diabetes, type II diabetes, nephropathy, inflammation of the intestine, neuroinflammatory disorders, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, obesity associated with diabetes, and for the treatment of pain, neuropathic pain, neurogenic pain, cancer pain, peri-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, pediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox- Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory connective tissue diseases, arthritis, neurodegenerative diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, cerebral palsy, brain, movement, ocular motility, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse, autism, nausea, vomiting, loss of appetite, muscle tension, muscle spasms, epilepsy, glaucoma, arthritis, Parkinson's disease, gastrointestinal illness, anxiety, bi-polar disorder, depression, insomnia, and for topical treatment of skin inflammation, namely, eczema, psoriasis, atopic dermatitis, acne, rosacea, lichen planus, bullous pemphigold, vasculitis, granuloma annulare and erythroderma; Medicinal herbs, medicinal oils, medicinal infusions for treating metabolic diseases and disorders, namely, diabetes, type II diabetes, nephropathy, inflammation of the intestine, neuroinflammatory disorders, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, obesity associated with diabetes, and for the treatment of pain, neuropathic pain, neurogenic pain, cancer pain, peri-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, pediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, and Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory connective tissue diseases, arthritis, neurodegenerative diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, cerebral palsy, brain, movement, ocular motility, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse, autism, nausea, vomiting, loss of appetite, muscle tension, muscle spasms, epilepsy, glaucoma, arthritis, Parkinson's disease, gastrointestinal illness, anxiety, bi-polar disorder, depression, insomnia, and for topical treatment of skin inflammation, namely, eczema, psoriasis, atopic dermatitis, acne, rosacea, lichen planus, bullous pemphigold, vasculitis, granuloma annulare and erythroderma; Appetite suppressants for medical purposes; Botanical, herbal, nutraceutical, dietary and nutritional supplements for general health and well-being; Botanical, herbal, nutraceutical, dietary and nutritional preparations and botanical, herbal, nutraceutical, dietary and nutritional substances containing plant extracts and plant-derived nutrients to reduce stress and fatigue, increase appetite, reduce anxiety, relax tension, mood enhancement and provide an improved sense of well-being; Dietary supplements in the form of powder for general health and well-being; Dietary supplements in the form of capsules for general health and well-being; Dietary supplements in the form of drops and liquids for general health and well-being; Veterinary preparations for the treatment of long-term neurogenic pain, muscle spasms, muscle cramps, reduced appetite, weight loss, and vomiting in livestock animals, farm animals, pet animals, and domestic animals; Veterinary preparations, namely, pain relief medication; Pharmaceutical and veterinary preparations for the treatment of pain and the induction of sedation, anxiety relief, and pain relief during therapeutic and diagnostic procedures; Nutritional supplement in the nature of a protein-based drink mix; Protein dietary supplements; Protein supplement shakes; Protein supplements; Protein supplements for animals; Drug dispensing devices used by patients and physicians which can record and transmit medical data associated with drug management process; Medical information charts; Pharmaceutical information leaflets; Printed and electronic medical publications; Hemp; Clothing, namely, T- shirts, shirts, polo shirts, hats, caps, sweat shirts, sweat pants, shorts, socks, footwear and jackets; Edible oils; Hemp protein and hemp oil for human consumption, hemp protein and hemp oil for use as a food additive, hemp milk and hemp milk powder for nutritional purposes; Herb-based nutritional food bars; Herb-based energy bars; Herb-based meal replacement bars; Processed edible seeds; Hemp and hemp-based beverages, beverages made of hemp; Herbal tea beverages; Meal replacement drinks; Tea extracts; Granola bars, granola-based snack bars, cereal-based bars; Chocolates; Candies; Gummies; Chewing gums; Bakery goods, namely, cupcakes, cakes, muffins, pastries, cookies, biscuits, scones, loafs, breads and buns, brownies and pies; Agricultural and horticultural products, namely, natural plants and flowers, living plants, plant cuttings, seeds for horticultural purposes, agricultural seeds, dried plants, hemp seeds, herbs for culinary purposes; Unprocessed edible seeds; Edible treats for pets; Paraphernalia for smoking, namely, rolling papers, vaporizers, diffusers, grinders, smoking pipes, and scales | ACTIVE | — |
| 035 | Retail sale and sale of natural plants and flowers, living plants, plant cuttings, agricultural seeds, dried plants, hemp, hemp seeds, herbs for medical purposes, botanical and botanically derived products, namely, dietary and nutritional supplements, pharmaceutical preparations, veterinary preparations, food and beverages, hemp based food products, cosmetics, body care and toiletry products and clothing accessible on-line and by telephone, facsimile and mail order; Wholesale sale and online sale services in the field of botanical and botanically derived products, namely, dietary and nutritional supplements, pharmaceutical preparations, veterinary preparations, food and beverages, hemp based food products, cosmetics, body care and toiletry products and clothing; Organization of alternative medicine exhibition for commercial or adverting purposes; Distributorships in the field of botanical and botanically derived products, namely, dietary and nutritional supplements, pharmaceutical preparations, veterinary preparations, food and beverages, hemp based food products, cosmetics, body care and toiletry products and clothing; Distribution and transportation of natural plants and flowers, living plants, plant cuttings, agricultural seeds, dried plants, hemp, hemp seeds, herbs for medical purposes; Production and processing of natural plants and flowers, living plants, plant cuttings, agricultural seeds, dried plants, hemp, hemp seeds, herbs for medical purposes; Organization of alternative medicine exhibition for educational purposes; Design, research and development of advanced plant-cultivation methods and technologies for use in the pharmaceutical, nutraceuticals, food products and cosmetic industries; Developing technologies to improve plant growth, production and extraction technologies to maximize production of pharmaceutical grade plant extracts; Medical services; Medical services, namely, medical laboratory, research, analysis, diagnostic, and testing services; Pharmaceutical research and development; Development of pharmaceutical, botanical and nutraceutical preparations and medicines; Clinical research in the field of medicine; Veterinary services; Providing medical information; Medical counseling, providing access to a computer database containing medical information; Providing access to a medical database via a global information network; Publishing and issuing scientific papers in relation to medical technology; Horticultural services; Cultivation and breeding of natural plants and flowers, living plants, plant cuttings, agricultural seeds, dried plants, hemp, hemp seeds, herbs for medical purposes; Preparation and dispensing of medications and pharmaceuticals; Operating a website featuring information regarding nutrition, health, wellness, healthy living and lifestyles, recipes and cooking tips and diet information based on hemp, hemp oil, CBD (Cannabidiol) and other cannabinoids, and hemp and CBD (Cannabidiol) based food products and dietary and nutritional supplements; Educational services, namely, the publication of movies, films, audio digital online recordings, electronic newsletters, electronic magazines, and electronic magazine articles featuring information about hemp, hemp oil, CBD (Cannabidiol) and other cannabinoids, and hemp and CBD (Cannabidiol) based food products and dietary and nutritional supplements; Educational services and Internet based content and information, namely, websites, on-line journals, blogs, and newsletters about nutrition, health, wellness, healthy living and lifestyles, recipes and cooking tips, diet information based on hemp, hemp oil, CBD (Cannabidiol) and other cannabinoids, and hemp and CBD (Cannabidiol) based food products and dietary and nutritional supplements; Production and publication of seminars, workshops, webinars, classes and training sessions in the fields of nutrition, health, wellness, healthy living and lifestyles, recipes and cooking tips and diet information based on hemp, hemp oil, CBD (Cannabidiol) and other cannabinoids, and hemp and CBD (Cannabidiol) based food products and dietary and nutritional supplements | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 19, 2019 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 16, 2019 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 17, 2019 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jan 17, 2019 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jan 17, 2019 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jan 11, 2019 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jul 11, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 11, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 11, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 10, 2018 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 22, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Dec 22, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Dec 22, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Dec 4, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 4, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 1, 2017 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Dec 1, 2017 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jun 1, 2017 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jun 1, 2017 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jun 1, 2017 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| May 17, 2017 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| May 5, 2017 | ALIE | ASSIGNED TO LIE | — |
| Oct 26, 2016 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 26, 2016 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 26, 2016 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 5, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 4, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 4, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 4, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 4, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 4, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 4, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 21, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 11, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 24, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 23, 2015 | NWAP | NEW APPLICATION ENTERED | — |